share_log

太龙药业(600222.SH):3月公司未实施股份回购

Tailong Pharmaceutical (600222.SH): The company did not implement share repurchases in March

Gelonghui Finance ·  Apr 1 05:34

Gelonghui, April 1, 丨 Tailong Pharmaceutical (600222.SH) announced that in March 2024, the company did not implement a share repurchase. As of March 31, 2024, the company has repurchased 1,205,200 shares, accounting for 0.21% of the company's total share capital. The highest price of the repurchase transaction was 4.32 yuan/share, the lowest price was 3.82 yuan/share, and the total amount paid was 4,955,198.00 yuan (excluding transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment